Cue Biopharma, Inc. (CUE) is a publicly traded Healthcare sector company. As of May 21, 2026, CUE trades at $20.03 with a market cap of $86.50M and a P/E ratio of -16.45. CUE moved -1.53% today. Year to date, CUE is +77.99%; over the trailing twelve months it is +1.70%. Its 52-week range spans $4.97 to $59.67. Rallies surfaces CUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CUE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $20.03 |
| Market Cap | $86.50M |
| P/E Ratio | -16.45 |
| EPS | $-1.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $59.67 |
| 52-Week Low | $4.97 |
| Volume | 386 |
| Avg Volume | 0 |
| Revenue (TTM) | $32.73M |
| Net Income | $-19.52M |
| Gross Margin | 0.00% |
CUE analyst coverage data. Average price target: $0.00.